Cargando…

Prognostic Implication of YY1 and CP2c Expression in Patients with Primary Breast Cancer

SIMPLE SUMMARY: YY1 and CP2c is a transcription factor that regulates epigenetic pathways and protein modifications among several kinds of cancer. However, it is still unknown whether YY1 expression has any prognostic significance in patients with breast cancer. Thus, we investigated YY1 expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Chihwan David, Son, Seung Han, Kim, Chul Geun, Park, Hosub, Chung, Min Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340759/ https://www.ncbi.nlm.nih.gov/pubmed/37444605 http://dx.doi.org/10.3390/cancers15133495

Ejemplares similares

Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma
por: Kim, Ji Sook, et al.
Publicado: (2017)

YY1 and CP2c in Unidirectional Spermatogenesis and Stemness
por: Cheon, Yong-Pil, et al.
Publicado: (2020)

ASAP1 Expression in Invasive Breast Cancer and Its Prognostic Role
por: Park, Hosub, et al.
Publicado: (2023)

Loss of Single-Stranded DNA Binding Protein 2 Expression Is Associated with Aggressiveness and Poor Overall Survival in Patients with Invasive Breast Carcinoma
por: Park, Hosub, et al.
Publicado: (2022)

Structural and Functional Insights into CP2c Transcription Factor Complexes
por: Son, Seung Han, et al.
Publicado: (2022)

Decreased Expression of Cell Adhesion Molecule 4 in Gastric Adenocarcinoma and Its Prognostic Implications
por: Bang, Seongsik, et al.
Publicado: (2022)

Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
por: Yoon, Chang Ik, et al.
Publicado: (2020)

Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2
por: Kakizaki, Fumihiko, et al.
Publicado: (2016)

Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy
por: Bae, Soong June, et al.
Publicado: (2020)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Bae, Soong June, et al.
Publicado: (2022)

Genome-wide analysis of YY2 versus YY1 target genes
por: Chen, Li, et al.
Publicado: (2010)

Mbd2-CP2c loop drives adult-type globin gene expression and definitive erythropoiesis
por: Kim, Min Young, et al.
Publicado: (2018)

Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2022)

Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1
por: Kim, Jeong Do, et al.
Publicado: (2007)

Homeostasis Imbalance of YY2 and YY1 Promotes Tumor Growth by Manipulating Ferroptosis
por: Li, Yanjun, et al.
Publicado: (2022)

Clinicopathological Significance of Cell Adhesion Molecule 4 Expression in Gallbladder Cancer and Its Prognostic Role
por: Bang, Seongsik, et al.
Publicado: (2023)

Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis
por: Cha, Chihwan, et al.
Publicado: (2022)

CD47 Expression in Non-Melanoma Skin Cancers and Its Clinicopathological Implications
por: Bang, Seongsik, et al.
Publicado: (2022)

Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort
por: Schnoell, Julia, et al.
Publicado: (2020)

The hot corona of YY Mensae
por: Güdel, M, et al.
Publicado: (1996)

Effects of Cortactin Expression on Prognosis in Patients with Breast Cancer
por: Son, Hwangkyu, et al.
Publicado: (2023)

Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Park, Soeun, et al.
Publicado: (2021)

SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
por: Son, Seung Han, et al.
Publicado: (2023)

Differentially methylated CpG island within human XIST mediates alternative P2 transcription and YY1 binding
por: Chapman, Andrew G, et al.
Publicado: (2014)

Yy production by 5.7 GeV/c antiprotons in hydrogen
por: Bock, R, et al.
Publicado: (2016)

The anorexic hormone Peptide YY(3–36) is rapidly metabolized to inactive Peptide YY(3–34) in vivo
por: Toräng, Signe, et al.
Publicado: (2015)

Associations between absolute neutrophil count and lymphocyte-predominant breast cancer
por: Yoon, Chang Ik, et al.
Publicado: (2019)

CapsNetYY1: identifying YY1-mediated chromatin loops based on a capsule network architecture
por: Zhang, Zhimin, et al.
Publicado: (2023)

YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
por: Wang, Jianwei, et al.
Publicado: (2015)

The role of peptide YY in gastrointestinal diseases and disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013)

Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2021)

Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer
por: Vivarelli, Silvia, et al.
Publicado: (2022)

Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
por: Lee, Janghee, et al.
Publicado: (2020)

YY2 Promotes Osteoblast Differentiation by Upregulating Osterix Transcriptional Activity
por: Piao, Meiyu, et al.
Publicado: (2022)

The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors
por: Allouche, Abdelkader, et al.
Publicado: (2008)

YY super sperm lead to all male triploids and tetraploids
por: Zhou, Rong, et al.
Publicado: (2015)

Author Correction: Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
por: Lee, Janghee, et al.
Publicado: (2021)

Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast
por: Son, Seung Hyun, et al.
Publicado: (2014)

Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node‐positive, HER2‐positive breast cancer
por: Cha, Chihwan, et al.
Publicado: (2021)

H->yy couplings and cross sections with the ATLAS detector
por: Cerda Alberich, Leonor
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cb88eqekdiulc256uc57n36nqf